首页> 美国卫生研究院文献>Molecular Cancer >Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor trichostatin A in cervical cancer cells
【2h】

Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor trichostatin A in cervical cancer cells

机译:组蛋白脱乙酰基酶抑制剂曲古抑菌素A对人骨桥蛋白启动子的转录调控

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundTrichostatin A (TSA), a potent inhibitor of histone deacetylases exhibits strong anti-tumor and growth inhibitory activities, but its mechanism(s) of action is not completely understood. Osteopontin (OPN) is a secreted glycoprotein which has long been associated with tumor metastasis. Elevated OPN expression in various metastatic cancer cells and the surrounding stromal cells often correlates with enhanced tumor formation and metastasis. To investigate the effects of TSA on OPN transcription, we analyzed a proximal segment of OPN promoter in cervical carcinoma cells.
机译:背景Trichostatin A(TSA)是一种有效的组蛋白脱乙酰基酶抑制剂,具有很强的抗肿瘤和生长抑制活性,但其作用机理尚不完全清楚。骨桥蛋白(OPN)是一种分泌的糖蛋白,长期以来与肿瘤转移有关。各种转移性癌细胞和周围基质细胞中OPN的表达升高通常与肿瘤形成和转移增强有关。为了研究TSA对OPN转录的影响,我们分析了宫颈癌细胞中OPN启动子的近端片段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号